glp-1 drugs uses The revolution: What UAB researchers are discovering about how these work The GLP-1 Agonists and Obesity:

Abstract The ever-increasing number of drugs available to treat type 2 diabetes and the complexity of patients with this condition present a constant challenge when it comes to identifying the most appropriate treatment approach

Because so many questions exist about safety, efficacy, long-term effects and more, ASAM appropriately invited several scientists and clinicians to present the latest data on the role of GLP-1 RAs in addiction

Taylor SI, Yazdi ZS, Beitelshees AL

Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging

Additionally, GLP-1 promotes the growth and proliferation of pancreatic cells, inhibits glucagon secretion, and enhances peripheral tissue uptake of glucose, making it a key factor in maintaining stable blood glucose levels

Common, then rare: the same list, sorted by likelihood Real-world reporting databases echo the trial pattern, with nausea and constipation leading the list (Liu and colleagues, pharmacovigilance analysis, Frontiers in Endocrinology , 2022)